Publications Office of the EU
Spain-Alcalá de Henares: Antineoplastic agents - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Spain-Alcalá de Henares: Antineoplastic agents

Overview
  • Awarded
    10/04/2017
  • Today
    12/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Not available
Place of performance
NUTS code: Spain
Location of buyer
NUTS code: Not available
Business sector (Main CPV)
33652100 Antineoplastic agents
Total estimated contract value (excluding VAT)
713,279.78
Total final contract value (excluding VAT)
494,540.47 EUR
Procedure details
Tender reference number
PNSP HUPA 15/17
Description

PNSP Hupa 15/17, supply of Perjeta Vial 420 mg.

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
Spain
CPV code

33652100 - Antineoplastic agents

Award method
Not specified
Estimated value
713,279.78
Final contracted value
494,540.47 EUR
Award of contract
Official name: Roche Farma,S.A.U.
Postal address: calle Ribera del Loira, 50
Town: Madrid
Postal code: 28042
Country: ESP
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.